Quarterly report pursuant to Section 13 or 15(d)

Fair Value Disclosures - Estimate to Measure Contingent Consideration Unobservable Level 3 In-process R&D (Details)

v3.24.1.1.u2
Fair Value Disclosures - Estimate to Measure Contingent Consideration Unobservable Level 3 In-process R&D (Details)
Aug. 31, 2023
Probability of success for next development phase | Relief from Royalty Method | KIO-101  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.17
Probability of success for next development phase | Relief from Royalty Method | KIO-201 | Minimum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.17
Probability of success for next development phase | Relief from Royalty Method | KIO-201 | Maximum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.47
Probability of success for next development phase | Multi-Period Excess Earnings Method | KIO-104 | Minimum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.17
Probability of success for next development phase | Multi-Period Excess Earnings Method | KIO-104 | Maximum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.18
Probability of success for next development phase | Multi-Period Excess Earnings Method | KIO-301 | Minimum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.17
Probability of success for next development phase | Multi-Period Excess Earnings Method | KIO-301 | Maximum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.67
Payment discount rate | Relief from Royalty Method | KIO-101  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.30
Payment discount rate | Relief from Royalty Method | KIO-201  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.30
Payment discount rate | Multi-Period Excess Earnings Method | KIO-104  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.25
Payment discount rate | Multi-Period Excess Earnings Method | KIO-301  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.25